Printer Friendly
The Free Library
19,604,530 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Continued Strong Growth for Smith & Nephew.


Business Editors & Health/Medical Writers

LONDON--(BW HealthWire)--Aug. 1, 2002

Smith & Nephew NEPHEW, dom. rel. The son of a person's brother or sister. Amb. 514; 1 Jacob's Ch. R. 207.  plc (NYSE NYSE

See: New York Stock Exchange
: SNN SNN Samenwerkingsverband Noord-Nederland
SNN Sanane Inc.
SNN Schoolnet News Network (Canada)
SNN Shannon, Ireland - Shannon (Airport Code)
SNN Special Needs Network
SNN Sarimanok News Network
), the global medical devices company, today announces its interim results for the half year ended June June: see month.  29, 2002.

Key points:
- Underlying sales up 14%

- Acquisitions added another 4% to sales

- Profit before tax and exceptional items up 13%

- EPS before exceptional items up 11%, underlying EPS up 18%

- Further progress expected in second half


Dudley Dudley, city (1991 pop. 186,513) and metropolitan district, W central England. Dudley's famed iron, coal, and limestone industries began declining c.1870. Other industries include engineering works, steelworks, metallurgy, glass cutting, textiles, and leatherworking.  Eustace Eustace may refer to the following :

People:
  • Eustace I of Boulogne
  • Eustace II of Boulogne
  • Eustace III of Boulogne
  • Eustace IV of Boulogne
  • Eustace Bishop of Ely and Lord Chancellor of England
  • Eustace of Fauconberg
  • Eustace of Luxeuil
, Chairman, said: "All businesses are performing well and demand for our products continues to be strong worldwide. Our sales performance was robust in all our businesses and our Orthopaedics orthopaedics Orthopedics  division was again the fastest growing manufacturer of hip and knee implants. We are therefore well placed to make further progress in the second half and beyond."

A presentation for analysts will be held at the City Presentation Centre, 4 Chiswell Street, Finsbury Coordinates:  Finsbury is a place in the south of the London Borough of Islington. The name is first recorded as Vinisbir (1231) and means "manor of a man called Finn.  Square, London London, city, Canada
London, city (1991 pop. 303,165), SE Ont., Canada, on the Thames River. The site was chosen in 1792 by Governor Simcoe to be the capital of Upper Canada, but York was made capital instead. London was settled in 1826.
 EC1Y 4UP at 9:30 am (UK) today. A tele-conference call for analysts will be held at 10 am (Eastern) / 3 pm (UK) today and will be webcast on www.smith-nephew.com/interimreport. Please call Jeff Caravella at Taylor Taylor, city (1990 pop. 70,811), Wayne co., SE Mich., a suburb of Detroit adjacent to Dearborn; founded 1847 as a township, inc. as a city 1968. A small rural village until World War II, it developed significantly in the second half of the 20th cent.  Rafferty Rafferty or Rafferty's rules
Noun, pl

Austral & NZ slang no rules at all [origin unknown]
 on (212)889-4350 for details. The morning meeting will be webcast and an archive version available on www.smith-nephew.com/interimreport. High-resolution high-res·o·lu·tion
adj.
1. Relating to an image that has fine detail.

2.
a. Of or relating to an output device that produces images that contain a large number of dots per unit of area and are therefore sharp and
 photographs are available to the media free of charge at www.newscast newscast

Radio or television broadcast of news events. News gathering and broadcasting by the radio networks began in the mid-1930s and increased significantly during World War II. The television newscast began in 1948 with 15-minute programs that resembled movie newsreels.
.co.uk

Trading Results and Overview

Our markets throughout the world continued to be strong in the first half of 2002 and Smith & Nephew sustained its pace of growth. Demand for our products in orthopaedics, endoscopy endoscopy

Examination of the body's interior through an instrument inserted into a natural opening or an incision, usually as an outpatient procedure. Endoscopes include the upper gastrointestinal endoscope (for the esophagus, stomach, and duodenum), the colonoscope (for the
 and advanced wound management continues to be strong. For the third year running our orthopaedics business was the fastest growing implant implant /im·plant/ (im-plant´) to insert or to graft (tissue, or inert or radioactive material) into intact tissues or a body cavity.  company.

Sales in our ongoing businesses again performed strongly, rising 17%. Within this, underlying growth was 14%, aided by our program of new product launches and investment in sales forces. Sales price increases accounted for 1 1/2% of underlying growth. Adverse currency translation reduced overall sales growth by 1%.

We are also selectively making acquisitions to augment aug·ment  
v. aug·ment·ed, aug·ment·ing, aug·ments

v.tr.
1. To make (something already developed or well under way) greater, as in size, extent, or quantity:
 our business base, and these accounted for 4% of reported sales growth in the first half. As part of this acquisition program, we purchased ORATEC Interventions, Inc., in March, in order to gain a strong base in radio frequency technology for minimally invasive surgery minimally invasive surgery Laparoscopic surgery, see there. See Laparoscopic cholecystectomy. .

In March, we completed our restructuring restructuring - The transformation from one representation form to another at the same relative abstraction level, while preserving the subject system's external behaviour (functionality and semantics).  programme with the disposal of Rehabilitation rehabilitation: see physical therapy.  to AbilityOne for (pound)71m paid in cash, plus a 21 1/2% retained interest Retained interest (also colloquially known as a payout penalty) is future, currently unpaid, interest that some lenders add to the remaining principal of a loan to determine a payout figure in the event that the loan is terminated before the completion of the original term.  in the enlarged company so as to benefit from the substantial value we believe will be created by combining the two businesses.

Ongoing margins of 16 1/2% are after absorbing 1% of dis-synergies from last year's divestments and Rehabilitation this year and from incorporating goodwill amortisation Noun 1. amortisation - the reduction of the value of an asset by prorating its cost over a period of years
amortization

reduction, step-down, diminution, decrease - the act of decreasing or reducing something

2.
 on the ORATEC acquisition.

Profit before tax and exceptional items amounted to (pound)94m, an increase of 13%. This comprises (pound)87m of operating profit Operating profit (or loss)

Revenue from a firm's regular activities less costs and expenses and before income deductions.


operating profit

See operating income.
 from ongoing operations, (pound)2m of profit from discontinued operations Discontinued operations

Divisions of a business that have been sold or written off and that no longer are maintained by the business.
 (principally Rehabilitation), an (pound)11m share of the profits of BSN BSN
abbr.
Bachelor of Science in Nursing
 Medical and AbilityOne, less (pound)6m of interest cost. Amortization of acquisition goodwill charged to operating profit was (pound)8m, of which (pound)2m related to ORATEC.

Earnings per share, exceptional items and cash flow

The effective ordinary tax charge was 32%, resulting in earnings per share before exceptional items of 6.89p, an 11% increase. Adjusting for the dilutive effects Dilutive effect

Result of a transaction that decreases earnings per common share (EPS).
 of the disposals this and last year, the formation of the BSN Medical joint venture and from incorporating goodwill amortization on the acquisition of ORATEC, the underlying increase in earnings per share before exceptional items was 18%.

Exceptional items comprise profit on disposals of (pound)19m, principally Rehabilitation, less (pound)9m of rationalization rationalization, in psychology: see defense mechanism.  and acquisition integration costs and an (pound)8m write down in the value of our equity investment in Advanced Tissue Sciences, Inc.

Operating cash flow Operating cash flow

Earnings before depreciation minus taxes. Measures the cash generated from operations, not counting capital spending or working capital requirements.
 was (pound)38m after (pound)9m of outgoings outgoings
Noun, pl

expenses

outgoings
plural noun expenses, costs, payments, expenditure, overheads, outlay

outgoings npl (
 on rationalization and acquisition integration. The net cost of acquisitions, principally ORATEC, was (pound)194m and the proceeds from disposing of Rehabilitation were (pound)71m. Net debt closed at (pound)350m after benefiting from (pound)28m of currency translation.

Dividend

An interim dividend of 1.80 pence pence  
n. Chiefly British
A plural of penny.


pence
Noun

a plural of penny
USAGE: Since the decimalization of British currency and the introduction of the abbreviation p,
 per share (2001: 1.75 pence) will be paid on November November: see month.  15, 2002 to shareholders on the register at the close of business on October October: see month.  18, 2002. Shareholders may participate in the company's dividend reinvestment plan Dividend Reinvestment Plan (DRP)

Plan which provides for automatic reinvestment of shareholder dividends in more shares of a company's stock, often without commissions. Some plans provide for the purchase of additional shares at a discount to market price.
.

Operating Review

Orthopaedics

Demand for hip and knee replacements and for trauma products shows no sign of diminishing di·min·ish  
v. di·min·ished, di·min·ish·ing, di·min·ish·es

v.tr.
1.
a. To make smaller or less or to cause to appear so.

b.
. Our orthopaedics business achieved increased underlying growth of 20%, maintaining its position as the fastest growing manufacturer of orthopedic orthopedic /or·tho·pe·dic/ (-pe´dik) pertaining to the correction of deformities of the musculoskeletal system; pertaining to orthopedics.  implants.

Hip and knee implants grew at 27% and trauma sales grew 8%. New products Oxinium Oxinium is the brand name of a material used for replacement joints manufactured by the reconstructive orthopedic surgery division of medical devices company Smith & Nephew.  and Supartz contributed 10% to implant sales growth, and took knees to a notable 37% growth. Hip sales grew at 16%.

Additional Oxinium knee components were launched in both the Genesis and Profix ranges. We continued to invest in computer aided surgery, where we achieved a 510k approval from the FDA FDA
abbr.
Food and Drug Administration


FDA,
n.pr See Food and Drug Administration.

FDA,
n.pr the abbreviation for the Food and Drug Administration.
 for knee procedures and extended our agreement for the development of software and instrumentation instrumentation, in music: see orchestra and orchestration.
instrumentation

In technology, the development and use of precise measuring, analysis, and control equipment.
 with Medtronic Medtronic Cardiology A major manufacturer of pacemakers, defibrillators, and other cardiac devices .

The forthcoming retirement of Larry Papasan as President of the Orthopaedics division and the appointment on May 1 of David Illingworth as his successor were announced.

Endoscopy

The requirement for minimally invasive surgery for injuries, mainly caused by sport, remains strong. Endoscopy achieved an underlying sales growth of 10% in the first half, with the acquisition of ORATEC at the end of March contributing an additional 6% to this. Arthroscopic repair performed strongly and Trivex, our technique for varicose vein varicose vein, superficial vessel that is abnormally lengthened, twisted, or dilated, seen most often on the legs and thighs. Varicose veins develop spontaneously, and are usually attributed to a hereditary weakness of the vein; the valves in the vein that keep the  removal, also made a useful impact.

Integration of ORATEC is proceeding to plan, with cost savings on target. We have already launched a bipolar (1) See bipolar transmission.

(2) One of two major categories of transistor; the other is "field effect transistor" (FET). Although the first transistors and first silicon chips were bipolar, most chips today are field effect transistors wired as CMOS logic, which
 radio-frequency resection resection /re·sec·tion/ (-sek´shun) excision.

root resection  apicoectomy.

transurethral resection of the prostate  (TURP), transurethral prostatic resection
 system to complement ORATEC's monopolar monopolar

having a single pole.
 tissue shrinkage Shrinkage

The amount by which inventory on hand is shorter than the amount of inventory recorded.

Notes:
The missing inventory could be due to theft, damage, or book keeping errors.
 products.

We continue to improve the percentage of new products to sales in Endoscopy and to date this year have achieved 15%. The addition of the new radio-frequency products from ORATEC and our FasT-Fix and TwinFix suturing su·ture  
n.
1.
a. The process of joining two surfaces or edges together along a line by or as if by sewing.

b. The material, such as thread, gut, or wire, that is used in this procedure.

c.
 devices will accelerate this still further.

Both the new headquarters in Andover, Massachusetts Massachusetts (măsəch`sĭts), most populous of the New England states of the NE United States. , and our extended Mansfield, Massachusetts Mansfield is a town in Bristol County, Massachusetts, United States. As of the United States 2000 Census, the town population was 22,414.

For geographic and demographic information on the village of Mansfield Center, please see the article Mansfield Center, Massachusetts.
, manufacturing facility are now fully operational.

Advanced wound management

The growing population of elderly people underpins the strong demand for our advanced wound healing wound healing Physiology The repair of a wound Steps Inflammation, repair and closure, remodeling, final healing; repair of incisions may be either simple–'clean' wounds with little loss of tissue heal by 'primary intention', or 'dirty' wounds heal by  products, a market we continue to lead. Sales in advanced wound management grew at an underlying 11%, with a further 8% arising at the half year from the acquisitions of Beiersdorf's advanced wound management business and Acticoat Acticoat Wound care A silver nitrate-based antibacterial burn dressing for wound protection. See Pressure ulcer.  last year.

Our lead product Allevyn again demonstrated strong sales growth of 23% and we continue to develop this range to meet new needs. Our burns products continue to do well and the global rollout of Acticoat, the silver-based dressing, is being met with enthusiasm by wound management specialists and nurses.

Dermagraft, our bio-engineered dermis dermis: see skin.  for patients with hard to heal diabetic foot diabetic foot A foot with a constellation of pathologic changes affecting the lower extremity in diabetics, often leading to amputation and/or death due to complications; the common initial lesion leading to amputation is a nonhealing skin ulcer, induced by  ulcers Ulcers (Digestive) Definition

In general, an ulcer is any eroded area of skin or a mucous membrane, marked by tissue disintegration. In common usage, however, ulcer usually is used to refer to disorders in the upper digestive tract.
, received initial reimbursement Reimbursement

Payment made to someone for out-of-pocket expenses has incurred.
 approval in the US in April. Sales and extension of reimbursement coverage across the US are meeting their respective targets.

BSN Medical joint venture

At BSN, trading and integration rationalization remains on target, with a consequential con·se·quen·tial  
adj.
1. Following as an effect, result, or conclusion; consequent.

2. Having important consequences; significant:
 improvement in profitability to a 12% margin.

Outlook

We are pleased with the progress of the Group and particularly with the strong growth and increased market share in orthopaedics. Our investment in new products and strengthened sales force is paying off. Our underlying margins continue to improve and we expect this to continue in the second half of the year.

The medical devices sector continues to demonstrate strong growth characteristics and we expect to make further progress in the second half of the year and beyond.

Smith & Nephew is a global advanced medical devices company with a highly successful track record in developing, manufacturing and marketing a wide variety of innovative and technologically advanced tissue repair products. These products are primarily in the areas of bone, joints, skin and other soft tissue. Smith & Nephew has extensive marketing and distribution capabilities, with established sales in more than 90 countries.

Smith & Nephew ADRs, each equivalent to ten ordinary shares, trade on the New York Stock Exchange New York Stock Exchange (NYSE)

World's largest marketplace for securities. The exchange began as an informal meeting of 24 men in 1792 on what is now Wall Street in New York City.
 under the symbol SNN. Smith & Nephew ordinary shares trade on the London Stock Exchange London Stock Exchange

London marketplace for securities. It was formed in 1773 by a group of stockbrokers who had been doing business informally in local coffeehouses.
. Shares are quoted on the SEAQ SEAQ

See: Stock Exchange Automated Quotation System
 System, and prices may be accessed on the Reuter Equities 2000 Service under the symbol SMN SMN Survival Motor Neuron
SMN Servicio Meteorologico Nacional (Spanish: National Meteorological Service)
SMN Santa Maria Novella (church and main train station, Florence, Italy)
SMN Summoner
.L, on Bloomberg Bloomberg

A major global provider of 24-hour financial news and information including real-time and historic price data, financials data, trading news and analyst coverage, as well as general news and sports.
 under the symbol SNN, and on Quotron under the symbol SMU SMU Southern Methodist University
SMU Solid (Waste) Management Unit
SMU Saint Mary's University (Halifax, Nova Scotia; Philippines)
SMU Singapore Management University
SMU Saint Mary's University of Minnesota
.EU. For further information, visit Smith & Nephew's website at http://www.smith-nephew.com.


                          SMITH & NEPHEW plc
                   2002 INTERIM RESULTS continued

               Unaudited Group Profit and Loss Account
                 for the Half Year Ended June 29, 2002

       Year                                                    2001
       2001                                         2002    Restated#
     (pound)m                             Notes   (pound)m   (pound)m

                 Turnover                 1,2
       943.0     Ongoing operations                531.9        454.1
        35.3     Operations contributed
        ----      to the joint venture                -          35.3
                                                 --------      ------
       978.3     Continuing operations             531.9        489.4
       103.4     Discontinued operations   3        26.2         58.4
       -----                                      ------       ------
     1,081.7     Group turnover                    558.1        547.8
       123.6     Share of joint venture             79.3         41.9
       -----                                        ----         ----
     1,205.3                                       637.4        589.7
     =======                                       =====        =====

                 Operating profit
                 Ongoing operations
       160.4      - before exceptional
                     items                          87.1         77.7
       (19.3)     - exceptional items*     5       (15.3)       (14.0)
       -----                                      ------        -----
       141.1                                        71.8         63.7
                 Operations contributed to
                  the joint venture
         3.6      - before exceptional
                     items                 2          -           3.6
        (1.8)     - exceptional items*     5          -            -
       -----                                      ------       ------
       142.9     Continuing operations              71.8         67.3
        11.1     Discontinued operations   3         2.1          6.9
       -----                                       -----       ------
       154.0                                        73.9         74.2
                 Share of operating profit
                  of the joint venture
        12.8      - before exceptional
                     items                 2         9.4          4.0
        (5.0)     - exceptional items*     6        (1.3)        (2.5)
       -----                                       -----        -----
       161.8                                        82.0         75.7
           -     Share of operating profit
                  of the associated
                  undertaking              3         1.4           -
      ------                                      ------       ------
       161.8                                        83.4         75.7
        49.2     Discontinued operations
                  - net profit on
                     disposals*            3        19.0         47.1
       -----                                      ------       ------
       211.0     Profit on ordinary activities
                  before interest                  102.4        122.8
       (17.4)    Interest                  7        (6.3)        (9.5)
       -----                                      ------       ------
       193.6     Profit on ordinary activities
                  before taxation                   96.1        113.3
        64.0     Taxation                  8        45.5         41.2
       -----                                       -----        -----
       129.6     Attributable profit                50.6         72.1

        42.9     Ordinary dividends        9        16.7         16.1
       -----                                       -----        -----
        86.7     Retained profit                    33.9         56.0
       =====                                       =====        =====
       14.07p    Basic earnings per       10        5.46p        7.84p
                  ordinary share
       13.95p    Diluted earnings per
                  ordinary share          10        5.42p        7.76p

                 Results before
                  exceptional items (*)
(pound)170.5m    Profit before taxation   11 (pound)93.7m (pound)82.7m
       12.83p    Adjusted basic earnings
                  per ordinary share      10        6.89p        6.20p
       12.72p    Adjusted diluted earnings
                  per ordinary share      10        6.84p        6.14p

# See note 13


                          SMITH & NEPHEW plc
                   2002 INTERIM RESULTS continued

           Abridged Group Balance Sheet as at June 29, 2002
 Year                                                         2001
 2001                                             2002      Restated#
(pound)m                                 Notes   (pound)m   (pound)m
          Fixed assets

 187.8   Intangible assets                         332.8        186.5
 245.0   Tangible assets                           248.9        233.5
 114.0   Investment in joint
          venture(A)                        2      112.4        135.3
    -    Investment in associated
          undertaking(B)                    3        7.5            -
  25.7   Investments                                17.7         26.1
 -----                                             -----        -----
 572.5                                             719.3        581.4
 -----                                             -----        -----

         Working capital
 232.2   Stocks                                    241.6        224.5
 263.2   Debtors                                   280.4        277.3
 (21.7)  Creditors  - acquisition
                       consideration               (18.2)       (23.1)
(302.8)             - other                       (303.1)      (290.5)
 -----                                             -----        -----
 170.9                                             200.7        188.2
 (55.4)  Provisions - deferred taxation            (54.8)       (55.6)
 (39.9)             - other                        (37.2)       (47.3)
 -----                                             -----        -----
 648.1                                             828.0        666.7
 =====                                             =====        =====

 404.6   Share capital and reserves                477.9        369.1
 243.5   Net borrowings                            350.1        297.6
 -----                                             -----        -----
 648.1                                             828.0        666.7
 =====                                             =====        =====

(A) Investment in joint venture comprises goodwill (pound)71.3 million
    and share of gross assets of (pound)107.8 million less share of
    gross liabilities (pound)66.7 million.

(B) Investment in associated undertaking comprises goodwill
    (pound)15.9 million and share of gross assets of (pound)12.5
    million less share of gross liabilities (pound)20.9 million.


               Abridged Movement in Shareholders' Funds
                 for the Half Year Ended June 29, 2002

 Year                                                         2001
 2001                                             2002      Restated#
(pound)m                                        (pound)m    (pound)m

 268.0     Opening shareholders' funds as
            previously reported                    404.6        329.6
     -     Adjustments on adoption of FRS 19          -         (61.6)
------                                           -------        -----
 268.0     Opening shareholders funds - restated   404.6        268.0
 129.6     Attributable profit                      50.6         72.1
 (42.9)    Dividends                               (16.7)       (16.1)
  (8.8)    Exchange adjustments                      6.0         (8.5)
  17.9     Goodwill on disposals/operations
            contributed to the joint venture        30.0         17.9
  31.8     Unrealized gain on formation of
            the joint venture                         -          31.8
  (2.1)    Movements relating to the QUEST          (0.4)          -
  11.1     Issue of shares                           3.8          3.9
------                                           -------      -------
 404.6        Closing shareholders' funds          477.9        369.1
======                                           =======      =======

# See note 13


                          SMITH & NEPHEW plc
                   2002 INTERIM RESULTS continued

    Abridged Group Cash Flow for the Half Year Ended June 29, 2002


 Year                                                         2001
 2001                                             2002      Restated#
(pound)m                                        (pound)m    (pound)m

  154.0        Operating profit                     73.9         74.2
   60.3        Depreciation and amortization(C)     43.9         30.4
  (22.4)       Working capital and provisions      (38.9)       (42.1)
  -----                                             ----         ----
  191.9        Net cash inflow from operating
                activities(D)                       78.9         62.5

  (72.6)       Capital expenditure and
  -----         financial investment               (41.2)       (31.0)
                                                    ----         ----
  119.3        Operating cash flow                  37.7         31.5

      -        Joint venture dividend                2.2           -
  (16.5)       Interest                             (5.2)        (9.3)
  (76.2)       Tax                                 (29.7)       (33.4)
  (42.0)       Dividends                           (26.8)       (25.8)
  (69.3)       Acquisitions                       (193.5)       (59.0)
   61.7        Disposals                            71.8         61.7
   12.6        Joint venture formation               5.7         (4.2)
    9.0        Issues of ordinary share
   ----         capital                              3.4          3.9
                                                  ------        -----
   (1.4)       Net cash outflow                   (134.4)       (34.6)

   (5.8)       Exchange adjustments                 27.8        (26.7)
 (236.3)       Opening net borrowings             (243.5)      (236.3)
 -------                                          ------       ------
 (243.5)       Closing net borrowings             (350.1)      (297.6)
 =======                                          ======       ======

(C) Includes goodwill amortisation of (pound)8.1 million ((pound)10.4
    million for full year 2001 and (pound)4.5 million at the half
    year) and (pound)8.0 million exceptional write down against the
    group's equity investment in Advanced Tissue Sciences, Inc.

(D) After (pound)9.1 million ((pound)23.5 million for full year 2001
    and (pound)12.2 million at the half year) of outgoings on
    rationalisation, acquisition integration and divestment costs.

            Statement of Total Recognized Gains and Losses
                 for the Half Year Ended June 29, 2002

  Year                                                         2001
  2001                                             2002      Restated#
(pound)m                                        (pound)m     (pound)m

  129.6      Attributable profit                    50.6        72.1
   31.8      Unrealized gain on formation
              of the joint venture                    -         31.8
   (8.8)     Currency translation differences
              on foreign currency net investments    6.0        (8.5)
 ------                                            -----        ----
  152.6      Total recognized gains and losses      56.6        95.4
 ======                                            =====        ====

# See note 13


                          SMITH & NEPHEW plc
                   NOTES TO THE 2002 INTERIM RESULTS

1.  Segmental performance for the half year ended June 29, 2002 was as
    follows:

    Group Turnover by product

  Year
  2001                                       2002    2001   Underlying
(pound)m                                  (pound)m (pound)m   sales
                                                              growth

  404.6      Orthopaedics                    235.8    199.4      20%
  252.8      Endoscopy                       141.7    123.2      10%
  285.6      Advanced Wound Management       154.4    131.5      11%
-------                                      -----    -----      ---
  943.0      Ongoing operations              531.9    454.1      14%
                                             =====    =====      ===
   35.3      Operations contributed to the
              joint venture                     -      35.3
  103.4      Discontinued operations          26.2     58.4
-------                                       ----    ------
1,081.7                                      558.1    547.8
=======                                     =======  =======


    Group turnover by geographic market

  Year
  2001                                       2002    2001   Underlying
(pound)m                                  (pound)m (pound)m   sales
                                                              growth

  268.4      Europe*                         155.6    130.6      13%
  534.9      America                         303.1    257.6      14%
  139.7      Africa, Asia and Australasia     73.2     65.9      15%
 ------                                     ------   ------      ---
  943.0      Ongoing operations              531.9    454.1      14%
                                                                 ===
   35.3      Operations contributed to the
              joint venture                     -      35.3
  103.4      Discontinued operations          26.2     58.4
 ------                                       ----   ------
1,081.7                                      558.1    547.8
=======                                      =====    =====


*   Includes United Kingdom sales of (pound)40.8 million ((pound)77.5
    million for full year 2001 and (pound)37.0 million at the half
    year).

    Underlying sales growth is sales growth adjusted to eliminate the
    effect of translational currency, acquisitions and disposals.

2.  On April 1, 2001, the casting and bandaging and traditional
    woundcare businesses were contributed to a joint venture with
    Beiersdorf AG called BSN Medical in return for a 50% equity
    interest. The results of these businesses prior to contribution
    represent operations contributed to the joint venture in the group
    profit and loss account.

3.  On March 27, 2002, the rehabilitation business was disposed of to
    AbilityOne for (pound)71.3 million cash and a 21.5% equity
    interest in the combined business. AbilityOne is accounted for as
    an associated undertaking under the net equity method. The results
    of rehabilitation prior to disposal represent discontinued
    operations. The net profit on disposal of (pound)17.2 million is
    stated after deducting (pound)30.0 million of goodwill previously
    written off to reserves on acquisition. The remaining gain of
    (pound)1.8 million relates to adjustments in respect of previous
    disposals. Discontinued operations in 2001 also include the
    results and net profit on disposal of the ear, nose and throat
    business.

4.  On March 28, 2002, ORATEC Interventions, Inc., a company that
    applies radio frequency energy to treat joint and spine disorders,
    was acquired for a net consideration of(pound)190.6 million. The
    fair value of assets acquired was(pound)26.9 million and goodwill
    arising was(pound)163.7 million.

5.  Operating exceptional items within ongoing operations comprise an
    (pound)8.0 million write down against the group's equity
    investment in Advanced Tissue Sciences, Inc., (pound)3.1 million
    costs of rationalisation consequent on the contribution of
    businesses to BSN Medical and manufacturing rationalisation (2001
    half year (pound)8.7 million; full year (pound)10.4 million) and
    (pound)4.2 million of acquisition integration costs (2001 half
    year (pound)5.3 million; full year (pound)8.9 million). Operating
    exceptional items within operations contributed to the joint
    venture in 2001 represented manufacturing rationalisation costs.

6.  The group's share of exceptional items of the joint venture
    relates to manufacturing rationalisation costs of BSN Medical.

7.  Interest includes (pound)0.8 million (2001 - (pound)0.2 million)
    in respect of the group's share of the net interest charge of BSN
    Medical and (pound)0.3 million (2001 - nil) in respect of the
    group's share of the net interest charge of AbilityOne.

8.  The tax charge is based on an estimated effective rate of 32% on
    the full year's results before exceptional items and includes
    (pound)15.6 million in respect of the net exceptional items. Of
    the total, (pound)37.7 million relates to overseas taxation,
    (pound)2.6 million relates to the group's share of the tax of BSN
    Medical and (pound)0.3 million relates to the group's share of the
    tax of AbilityOne.

9.  An interim dividend of 1.80 pence per ordinary share (2001 - 1.75
    pence per ordinary share) will be paid on November 15, 2002 to all
    shareholders on the register at the close of business on October
    18, 2002. Shareholders may participate in the dividend
    reinvestment plan.

10. The basic average number of ordinary shares in issue was 926
    million (2001 - 920 million). The diluted average number of
    ordinary shares in issue was 933 million (2001 - 929 million).

11. Results before exceptional items state profit before taxation
    before charging the cost of exceptional items and the net profit
    on the disposal of discontinued operations. Adjusted earnings per
    ordinary share is based on the attributable profit before
    accounting for these items and associated taxationthereon.

12. The interim financial information has been prepared on the basis
    of the accounting policies set out in the full annual accounts of
    the group for the year ended December 31, 2001. The financial
    information contained in this interim statement does not
    constitute statutory accounts as defined in Section 240 of the
    Companies Act 1985.

13. Half year 2001 comparative figures have been restated for the
    adoption in the 2001 full year results of Financial Reporting
    Standard 19 and Urgent Issues Task Force Abstract 31.

14. The financial information for the year ended December 31, 2001 has
    been extracted from the full annual accounts of the group which
    have been filed with the Registrar of Companies. The auditors'
    report on those accounts was unqualified.


Independent Review Report to Smith & Nephew plc

We have been instructed by the company to review the financial information for the six months ended June 29, 2002 which comprises the Group Profit and Loss Account, Abridged Group Balance Sheet, Abridged Group Cash Flow Statement, Statement of Total Recognized Gains Recognized Gain

The amount of gain reported for income tax purposes.

Notes:
You can defer recognizing some gains until the following year(s).
See also: Capital Gain, Capital Loss, Deferred Income Tax, Drought Sale, Exempt Income, Exemption, Gain, Recognized Loss
 and Losses, Abridged Movement in Shareholders' Funds and the related notes 1 to 14. We have read the other information contained in the interim report and considered whether it contains any apparent misstatements or material inconsistencies with the financial information.

The interim report, including the financial information contained therein, is the responsibility of, and has been approved by the directors. The directors are responsible for preparing the interim report in accordance Accordance is Bible Study Software for Macintosh developed by OakTree Software, Inc.[]

As well as a standalone program, it is the base software packaged by Zondervan in their Bible Study suites for Macintosh.
 with the Listing Rules of the Financial Services Authority The Financial Services Authority ("FSA") is an independent non-departmental public body and quasi-judicial body that regulates the financial services industry in the United Kingdom. Its main office is based in Canary Wharf, London, with another office in Edinburgh.  which require that the accounting policies and presentation applied to the interim figures should be consistent with those applied in preparing the preceding annual accounts except where any changes, and the reasons for them, are disclosed.

We conducted our review in accordance with guidance contained in Bulletin 1999/4 `Review of interim financial information' issued by the Auditing Practices Board for use in the United Kingdom. A review consists principally of making enquiries of group management and applying analytical procedures Analytical Procedures is one of financial audit skill which help an auditor understand the client's business and changes in the business, to identify potential risk areas and to plan other audit procedures.  to the financial information and underlying financial data, and based thereon there·on  
adv.
1. On or upon this, that, or it.

2. Archaic Following that immediately; thereupon.

Adv. 1. thereon - on that; "text and commentary thereon"
on it, on that
, assessing whether the accounting policies and presentation have been consistently applied, unless otherwise disclosed. A review excludes audit procedures such as tests of controls and verification of assets, liabilities and transactions. It is substantially less in scope than an audit performed in accordance with United Kingdom Auditing Standards and therefore provides a lower level of assurance than an audit. Accordingly we do not express an audit opinion on the financial information.

On the basis of our review we are not aware of any material modifications that should be made to the financial information as presented for the six months ended June 29, 2002.

Ernst & Young LLP LLP - Lower Layer Protocol

London
COPYRIGHT 2002 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Comment:Continued Strong Growth for Smith & Nephew.
Publication:Business Wire
Geographic Code:1USA
Date:Aug 1, 2002
Words:3718
Previous Article:MAXIMUS Reports Record Revenue.
Next Article:ResCare Reports Second Quarter Earnings of $0.15 Per Share.



Related Articles
Strong Sales Growth Continues for Smith & Nephew.
Strong First Half Expected for Smith & Nephew.
Strong Full-Year Results Expected for Smith & Nephew; Medical Devices Company Continues to Sustain Business Growth.
Smith & Nephew Close Period Trading Update.
YOUTH BASEBALL: HART NEARS ENTRY TO ZONE.
Skin Care System.
Skin knows the difference--not all skin care products are created equal.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles